Form 8-K - Current report:
SEC Accession No. 0000950170-25-040248
Filing Date
2025-03-17
Accepted
2025-03-17 16:10:09
Documents
12
Period of Report
2025-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20250312.htm   iXBRL 8-K 50515
2 EX-99.1 fgen-ex99_1.htm EX-99.1 296704
  Complete submission text file 0000950170-25-040248.txt   476871

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20250312.xsd EX-101.SCH 24862
14 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20250312_htm.xml XML 4696
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 25744499
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)